Concepedia

Dana N. Loury

DN

18

Publications

686

Citations

15

H-Index

1984

Active since

Affiliations

University of California, Davis(Current)

Institute of Organic Chemistry

FX Palo Alto Laboratory

University of Hertfordshire

Dana N. Loury is an author at University of California, Davis specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1984–1999

18

Publications

18

Identification of a single α<sub>1</sub>‐adrenoceptor corresponding to the α<sub>1A</sub>‐subtype in rat submaxillary gland

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1989 · 112 citations · Full text

, , +18

Differences between the α<sub>2</sub>‐adrenoceptor in rat submaxillary gland and the α<sub>2A</sub>‐ and α<sub>2B</sub>‐adrenoceptor subtypes

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1989 · 102 citations · Full text

, , +20

[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.

D W Bonhaus, Dana N. Loury, Lyn B. Jakeman et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 60 citations · Full text

Characteristics of 5‐HT<sub>3</sub> binding sites in NG108‐15, NCB‐20 neuroblastoma cells and rat cerebral cortex using [<sup>3</sup>H]‐quipazine and [<sup>3</sup>H]‐GR65630 binding

Naj Sharif, Erik H.F. Wong, Dana N. Loury et al. · British Journal of Pharmacology · 1991 · 56 citations

Assessment of imiloxan as a selective α<sub>2B</sub>‐adrenoceptor antagonist

Anton D. Michel, Dana N. Loury, R.L. Whiting · British Journal of Pharmacology · 1990 · 50 citations · Full text

, , +14

Rows per page

1–5 of 18